Skip to main content
Top
Published in: Rheumatology International 3/2014

01-03-2014 | Short Communication

Association study of CRP gene in systemic sclerosis in European Caucasian population

Authors: Julien Wipff, Philippe Dieudé, Jérôme Avouac, Eric Hachulla, Jean-Luc Cracowski, Elisabeth Diot, Luc Mouthon, Jean Sibilia, Kiet Tiev, Olivier Meyer, André Kahan, Catherine Boileau, Yannick Allanore

Published in: Rheumatology International | Issue 3/2014

Login to get access

Abstract

Opsonization and apoptotic cell elements are critical in systemic lupus erythematosus (SLE) and could act through the activation of the innate immunity. C-reactive protein (CRP) belongs to opsonins, and polymorphisms of CRP gene have been shown to be associated with SLE susceptibility. Accumulating evidences show that SLE and systemic sclerosis (SSc) share some genetic susceptibility factors. To determine whether polymorphisms of CRP confer susceptibility to SSc, four SNPs (rs1130864, rs1205, rs1800947 and rs1341665), chosen using Hapmap linkage disequilibrium data and published data, were genotyped in a cohort of 651 SSc patients (569 with antinuclear antibodies, 258 with anti-centromere and 153 with anti-topoisomerase I) and 442 controls. All individuals were of French Caucasian origin. The four polymorphisms were in Hardy–Weinberg equilibrium in the control population. Allelic and genotypic frequencies for these four polymorphisms were found to be similar in SSc patients and controls. Moreover, subphenotype analyses in particular for subgroups having antinuclear antibodies did not detect any difference between SSc patients and controls. These results obtained through a large cohort of European Caucasian SSc patients do not support the implication of CRP gene in the pathogenesis of SSc.
Literature
1.
go back to reference Allanore Y, Dieude P, Boileau C (2010) Genetic background of systemic sclerosis: autoimmune genes take centre stage. Rheumatology 49:203–210PubMedCrossRef Allanore Y, Dieude P, Boileau C (2010) Genetic background of systemic sclerosis: autoimmune genes take centre stage. Rheumatology 49:203–210PubMedCrossRef
2.
go back to reference Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E et al (2009) Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 60:225–233PubMedCrossRef Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E et al (2009) Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 60:225–233PubMedCrossRef
3.
go back to reference Dieude P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E et al (2009) STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 60:2472–2479PubMedCrossRef Dieude P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E et al (2009) STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 60:2472–2479PubMedCrossRef
5.
go back to reference Iwata Y, Yoshizaki A, Ogawa F et al (2009) Increased serum pentraxin 3 in patients with systemic sclerosis. J Rheumatol 36:976–983PubMedCrossRef Iwata Y, Yoshizaki A, Ogawa F et al (2009) Increased serum pentraxin 3 in patients with systemic sclerosis. J Rheumatol 36:976–983PubMedCrossRef
6.
go back to reference Sibilia J, Pasquali JL (2008) Systemic lupus erythematosus: news and therapeutic perspectives. Presse Med 37:444–459PubMedCrossRef Sibilia J, Pasquali JL (2008) Systemic lupus erythematosus: news and therapeutic perspectives. Presse Med 37:444–459PubMedCrossRef
7.
8.
go back to reference Russell AI, Cunninghame Graham DS, Shepherd et al (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13:137–147PubMedCentralPubMedCrossRef Russell AI, Cunninghame Graham DS, Shepherd et al (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13:137–147PubMedCentralPubMedCrossRef
9.
go back to reference Edberg JC, Wu J, Langefeld CD, Brown EE, Marion MC, McGwin G Jr et al (2008) Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 17:1147–1155PubMedCrossRef Edberg JC, Wu J, Langefeld CD, Brown EE, Marion MC, McGwin G Jr et al (2008) Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 17:1147–1155PubMedCrossRef
10.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
11.
go back to reference Valentini G, Matucci Cerinic M (2007) Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 25:159–162PubMed Valentini G, Matucci Cerinic M (2007) Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 25:159–162PubMed
12.
13.
go back to reference Kravitz MS, Pitashny M, Shoenfeld Y (2005) Protective molecules—C-reactive protein (CRP), serum amyloid p (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein a1 (Apo a1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol 25:582–591PubMedCrossRef Kravitz MS, Pitashny M, Shoenfeld Y (2005) Protective molecules—C-reactive protein (CRP), serum amyloid p (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein a1 (Apo a1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol 25:582–591PubMedCrossRef
14.
go back to reference Hage FG, Szalai AJ (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 50:1115–1122PubMedCrossRef Hage FG, Szalai AJ (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 50:1115–1122PubMedCrossRef
15.
go back to reference Khanh TH, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80–93 Khanh TH, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80–93
Metadata
Title
Association study of CRP gene in systemic sclerosis in European Caucasian population
Authors
Julien Wipff
Philippe Dieudé
Jérôme Avouac
Eric Hachulla
Jean-Luc Cracowski
Elisabeth Diot
Luc Mouthon
Jean Sibilia
Kiet Tiev
Olivier Meyer
André Kahan
Catherine Boileau
Yannick Allanore
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 3/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2673-8

Other articles of this Issue 3/2014

Rheumatology International 3/2014 Go to the issue